| Business Summary | | PLC
Systems,
Inc.
has
developed
a
patented
high-powered
carbon
dioxide
laser
system,
known
as
The
Heart
Laser
(HL1),
for
use
in
the
treatment
of
severe
coronary
artery
disease
(CAD).
The
HL1
is
used
in
a
surgical
laser
procedure,
pioneered
by
the
Company
and
its
clinical
investigators,
known
as
transmyocardial
revascularization
(TMR).
In
January
2001,
the
Company
obtained
United
States
Food
and
Drug
Administration
(FDA)
approval
to
market
its
second-generation
laser,
the
CO(2)
Heart
Laser
2
(HL2).
The
HL2
is
less
than
half
the
weight
and
size
than
the
HL1,
but
delivers
the
equivalent
laser
energy,
wavelength
and
beam
characteristics. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PLC
Systems
is
a
multinational
manufacturer
of
medical
lasers
and
related
products.
PLC
has
patented
The
Heart
Laser,
a
CO2
laser
system.
For
the
six
months
ended
6/30/01,
revenues
decreased
8%
to
$4.9
million.
Net
loss
decreased
24%
to
$2.3
million.
Revenues
suffered
from
a
decrease
in
placement
and
service
fees.
Lower
loss
reflects
a
decrease
in
corporate
marketing,
travel
and
relocation
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Edward Pendergast, 67 Chairman | -- | Mark Tauscher, 48 Pres,
CEO, Director | $489K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|